Diabetes and the female disadvantage

Women's Health

Volumn 11, Issue 6, 2015, Pages 833-839

  Woodward, Mark ^a,b,c   Peters, Sanne Ae ^a   Huxley, Rachel R ^b,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

coronary heart disease; diabetes; stroke; women

Indexed keywords

GLUCOSE;

BODY FAT; CEREBROVASCULAR ACCIDENT; CORONARY RISK; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; ENVIRONMENTAL EXPOSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; SEX DIFFERENCE; CARDIOVASCULAR DISEASES; COMPLICATION; MALE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; STROKE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; STROKE;

EID: 84952050274     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.15.67     Document Type: Review

References (40)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 94(3), 311-321 (2011).
2. Collins GS, Mallett S, Omar O, Yu L-M. Developing risk prediction models for Type 2 diabetes: A systematic review of methodology and reporting. BMC Med. 9, 103 (2011).
3. Woodward M, Zhang X, Barzi F et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 26(2), 360-366 (2003).
4. Seshasai SR, Kaptoge S, Thompson A et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364(9), 829-41 (2011).
5. Sarwar N, Gao P, Seshasai SR et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 375(9733), 2215-2222 (2010).
6. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332(7533), 73-78 (2006).
7. Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: A systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet 383(9933), 1973-1980 (2014).
8. Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: A systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetalogia 57(8), 1542-1551 (2014).
9. Huxley RR, Peters SA, Mishra GD, Woodward M. Risk of all-cause mortality and vascular events in women versus men with Type 1 diabetes: A systematic review and meta-analysis. Lancet Diabetes Endocrinol. 3(3), 198-206 (2015).
10. Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: A prospective populationbased study. Am. J. Epidemiol. 118(4), 489-496 (1983)
11. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch. Intern. Med. 158(6), 617-621 (1998).
12. Leibson C. Loss of the female advantage with cardiovascular disease for women with diabetes. Lupus 8(5), 351-355 (1999).
13. Larsson CA, Gullberg B, Merlo J, Rastam L, Lindblad U. Female advantage in AMI mortality is reversed in patients with Type 2 diabetes in the Skaraborg Project. Diabetes Care 28(9), 2246-2248 (2005).
14. Woodward M, Huxley R. Increased risk of coronary heart disease in female smokers-authors reply. Lancet 379(9818), 803 (2012).
15. Peters SA, Huxley RR, Woodward M. Comparison of the sex-specific associations between systolic blood pressure and the risk of cardiovascular disease: A systematic review and meta-analysis of 124 cohort studies, including 1.2 million individuals. Stroke 44(9), 2394-2401 (2013).
16. Mongraw-Chaffin ML, Peters SA, Huxley RR, Woodward M. The sex-specific association between BMI and coronary heart disease: A systematic review and meta-analysis of 95 cohorts with 1.2 million participants. Lancet Diabetes Endocrinol. 3(6), 437-449 (2015).
17. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: A systematic review and meta-analysis of prospective cohort studies. Lancet 378(9799), 1297-1305 (2011).
18. Peters SA, Huxley RR, Woodward M. Smoking as a risk factor for stroke in women compared with men: A systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke 44(10), 2821-2828 (2013).
19. Go red for women. www.goredforwomen.org
20. Health and Social Care Information Centre. National Diabetes Audit 2012-2013-report 1: care processes and treatment targets 2014. www.hscic.gov.uk/catalogue/PUB14970
21. Eapen ZJ, Liang L, Shubrook JH et al. Current quality of cardiovascular prevention for Million Hearts: an analysis of 147,038 outpatients from The Guideline Advantage. Am. Heart J. 168(3), 398-404 (2014).
22. Green JS, Grant M, Hill KL, Brizzolara J, Belmont B. Heart disease risk perception in college men and women. J. Am. Coll. Health 51(5), 207-211 (2003).
23. Kirkman MS, Rowan-Martin MT, Levin R et al. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care 38, 604-609 (2015).
24. Paul S, Thomas G, Majeed A, Khunti K, Klein K. Women develop Type 2 diabetes at a higher body mass index than men. Diabetologia 55(5) 1556-1557 (2012).
25. Logue J, Walker JJ, Colhoun HM et al. Do men develop Type 2 diabetes at lower body mass indices than women? Diabetologia 54(12), 3003-3006 (2011).
26. Wannamethee SG, Papacosta O, Lawlor DA et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia 55(1), 80-87 (2012).
27. Lawes CMM, Parag V, Bennett DA et al. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 27(12), 2836-2842 (2004).
28. Bertram MY, Vos T. Quantifying the duration of prediabetes. Australian and Aus. NZJ Public Health 34(3), 311-314 (2010).
29. Kiencke S, Handschin R, von Dahlen R et al. Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur. J. Heart Fail. 12(9), 951-957 (2010).
30. Devereux RB, Roman MJ, Paranicas M et al. Impact of diabetes on cardiac structure and function: The Strong Heart Study. Circulation 101(19), 2271-2276 (2000).
31. Galderisi M, Anderson KM, Wilson PW et al. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy: The Framingham Heart Study. Am. J. Cardiol. 68(1), 85-89 (1991).
32. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heartfailure: The Framingham study. Am. J. Cardiol. 34(1), 29-34 (1974).
33. Bertoni AG, Krop JS, Anderson GF, Brancati FL. Diabetesrelated morbidity and mortality in a national sample of U.S. elders. Diabetes Care 25(3), 471-475 (2002).
34. Bell DS. Diabetic cardiomyopathy. Diabetes Care 26(10), 2949-2951 (2003).
35. Shah AD, Langenberg C, Rapsomaniki E et al. Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 3(2), 105-113 (2015).
36. diabetic cardiomyopathy: The Framingham Heart Study. Am. J. Cardiol. 68(1), 85-89 (1991).
37. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heartfailure: The Framingham study. Am. J. Cardiol. 34(1), 29-34 (1974).
38. Bertoni AG, Krop JS, Anderson GF, Brancati FL. Diabetesrelated morbidity and mortality in a national sample of U.S. elders. Diabetes Care 25(3), 471-475 (2002).
39. Bell DS. Diabetic cardiomyopathy. Diabetes Care 26(10), 2949-2951 (2003).
40. Shah AD, Langenberg C, Rapsomaniki E et al. Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 3(2), 105-113 (2015).